ArticleBMJ open2025
Add-on or switch to vibegron in patients with overactive bladder insufficiently responding to initial 4-week antimuscarinics: a randomised, parallel-group, multicentre trial (
Takanobu Yamamoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.